查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957635

2026年全球藥品穩定性和儲存服務市場報告

Pharmaceutical Stability And Storage Services Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥品穩定性和保藏服務市場經歷了顯著成長。預計該市場規模將從2025年的28.1億美元成長到2026年的29.9億美元，複合年成長率（CAGR）為6.1%。過去幾年的成長主要歸因於日益嚴格的藥品監管要求、全球藥品產量的成長、生物製藥生產的擴張、對藥品保存期限檢驗的需求以及臨床試驗數量的增加。

預計未來幾年，藥品穩定性和儲存服務市場將保持強勁成長，到2030年將達到37.8億美元，複合年成長率（CAGR）為6.1%。預測期內的成長要素包括生物製藥和細胞療法的擴張、藥品外包業務的增加、全球低溫運輸基礎設施的擴展、疫苗產量的增加以及對藥品穩定性監管的日益嚴格。預測期內的主要趨勢包括：對符合監管要求的儲存需求增加、穩定性測試服務外包業務的擴大、對低溫運輸和低溫儲存的需求不斷成長、生物製藥穩定性服務的增強以及對長期藥品品質保證的日益重視。

預計未來幾年，新藥核准數量的不斷成長將推動藥物穩定性測試和儲存服務市場的發展。新藥是指先前未核准使用或上市的新型藥物化合物。新藥核准數量的增加歸功於生物技術的進步，使得新化合物的發現成為可能，以及監管流程的改進，從而支持了更快、更有效率的藥物研發。新藥獲批數量的成長刺激了對藥物穩定性測試和儲存服務的需求，這些核准旨在確保藥物處於最佳儲存條件、符合監管要求並進行有效的儲存管理。例如，根據美國食品藥物管理局（FDA，負責保護公眾健康的美國聯邦機構）的數據，截至2023年10月，FDA在2022年核准了37種新藥，在2024年批准了50種新藥。這些藥物的研發正在推動癌症、罕見疾病、神經系統疾病、傳染病、感染疾病、思覺失調症和阿茲海默症疾病領域的治療。因此，新藥核准數量的不斷增加正在核准藥物穩定性和儲存服務市場的成長。

在藥品穩定性及儲存服務市場中，主要企業正致力於開發技術先進的解決方案，例如低溫儲存設施，以延長對溫度敏感的藥品的保存期限。低溫儲存設施是專門用於維持極低溫度（通常低於-150°C）的設施，旨在保護對溫度敏感的生物和藥品材料，例如細胞療法、疫苗和生物製藥。例如，總部位於英國的穩定性測試和生物樣本儲存公司Astriom於2024年12月在其位於愛爾蘭沃特福德郡特拉莫爾的工廠啟用了一座新的低溫儲存設施，顯著提升了其生物樣本的儲存能力。這座先進的設施旨在滿足日益成長的生物材料安全長期儲存需求，確保其在較長時間內保持活性。此儲存系統可提供低至-196°C的精確溫度控制、大容量儲存、符合ISO 9001認證的監管合規性，以及包括門禁控制和監控系統在內的先進安全措施。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球藥品穩定性和儲存服務市場：吸引力評分和分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術、循環經濟
    • 物聯網、智慧基礎設施、互聯生態系統
    • 生物技術、基因體學、精準醫療
  • 主要趨勢
    • 對符合法規要求的儲存設備的需求增加
    • 穩定性測試服務外包增加
    • 對低溫運輸和低溫儲存的需求增加
    • 拓展生物製藥穩定性測試服務
    • 人們越來越關注長期藥品品質保證

第5章 終端用戶產業市場分析

  • 生物製藥公司
  • 契約製造組織
  • 合約研究機構
  • 臨床試驗實施機構
  • 疫苗生產商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球藥品穩定性和儲存服務市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球藥品穩定性和儲存服務市場規模、比較和成長率分析
  • 全球藥品穩定性和儲存服務市場表現：規模和成長，2020-2025年
  • 全球藥品穩定性和儲存服務市場預測：規模和成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按服務
  • 穩定性、存儲
  • 依產品類型
  • 錠劑、膠囊、注射、口服懸浮液、複方製劑及其他產品類型
  • 按分子
  • 小分子、聚合物
  • 按模式
  • 內部、外包
  • 最終用戶
  • 生物製藥公司、契約製造組織、受託研究機構和其他最終用戶
  • 按類型細分：穩定性測試服務
  • 長期穩定性試驗、加速穩定性試驗、中期穩定性試驗、光穩定性試驗、強制分解試驗
  • 按類型細分：儲存服務
  • 室溫儲存、冷藏（2 度C至8 度C）、冷凍（-20 度C至-80 度C）、低溫儲存（-150 度C至-196 度C）以及受控活性原料藥和產品的儲存。

第10章 區域與國別分析

  • 全球藥品穩定性與儲存服務市場：按地區分類，歷史資料和預測資料（2020-2025年、2025-2030年預測、2035年預測）。
  • 全球藥品穩定性與儲存服務市場：按國家/地區分類，實際值和預測值，2020-2025 年、2025-2030 年預測值、2035 年預測值

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 藥品穩定性和儲存服務市場：競爭格局和市場佔有率，2024 年
  • 藥品穩定性和儲存服務市場：公司估值矩陣
  • 藥品穩定性和儲存服務市場：公司簡介
    • SGS SA
    • Eurofins Scientific SE
    • Intertek Group plc
    • Catalent Inc.
    • Almac Group

第37章 其他大型企業和創新企業

  • Alcami Corporation, Reading Scientific Services Ltd., Charles River Laboratories, Element Materials Technology Inc., Precision Stability Storage, Roylance Stability Storage Limited, BioLife Solutions Inc., Alloga UK Ltd., Auriga Research Private Limited, Q Laboratories Inc., ALS Limited, Lucideon Limited, Cencora Inc., PCI Pharma Services, DHL Life Sciences & Healthcare

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年藥品穩定性和儲存服務市場：提供新機會的國家
  • 2030年藥品穩定性和儲存服務市場：充滿新機會的細分市場
  • 2030年藥品穩定性與儲存服務市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH3MPSSS02_G26Q1

Pharmaceutical stability and storage services are specialized services designed to ensure that pharmaceutical products, including drugs, medications, and vaccines, retain their quality, efficacy, and safety over time. These services involve controlled storage environments for drugs, performing stability studies to track chemical, physical, and microbiological changes, and ensuring adherence to regulatory standards.

The primary pharmaceutical stability and storage services encompass stability and storage. Stability services evaluate how pharmaceutical products preserve their quality, potency, and safety under varying environmental conditions over time. These services are applied to a range of products including tablets, capsules, injectable solutions, oral suspensions, combination products, and more, and can involve both small and large molecules. They are offered through in-house and outsourcing models and are utilized by biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and others.

Tariffs have affected the pharmaceutical stability and storage services market by increasing the cost of imported temperature-control equipment, monitoring systems, storage containers, and facility components used in compliant storage environments. These impacts have been most pronounced in cryogenic and refrigerated storage segments, particularly in north america and europe where equipment sourcing is globally diversified. Asia-pacific service providers have faced capital cost pressures due to import dependencies. However, tariffs have encouraged domestic manufacturing of storage infrastructure and localized service expansion, improving supply security and operational resilience.

The pharmaceutical stability and storage services market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical stability and storage services market statistics, including pharmaceutical stability and storage services industry global market size, regional shares, competitors with a pharmaceutical stability and storage services market share, detailed pharmaceutical stability and storage services market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical stability and storage services industry. This pharmaceutical stability and storage services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.81 billion in 2025 to $2.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to strict pharmaceutical regulatory requirements, growth in global drug production, expansion of biologics manufacturing, need for shelf-life validation, increasing clinical trial volumes.

The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growth in biologics and cell therapies, increasing pharmaceutical outsourcing, expansion of global cold chain infrastructure, rising vaccine production, stronger regulatory scrutiny on drug stability. Major trends in the forecast period include rising demand for regulatory-compliant storage, increasing outsourcing of stability testing services, growing need for cold chain and cryogenic storage, expansion of stability services for biologics, higher focus on long-term drug quality assurance.

The rising number of novel drug approvals is expected to drive the growth of the pharmaceutical stability and storage services market in the coming years. A novel drug is a pharmaceutical compound that has been newly developed and has not been previously approved for use or marketed. The increase in novel drug approvals is attributed to advancements in biotechnology, which enable the discovery of new compounds, along with improved regulatory processes that support faster and more efficient drug development. The growth in novel drug approvals fuels the demand for pharmaceutical stability and storage services, ensuring optimal conditions, regulatory compliance, and effective shelf-life management. For example, in October 2023, according to the U.S. Food and Drug Administration (FDA), a US-based federal agency responsible for protecting public health, the FDA approved 37 novel drugs in 2022, followed by 50 in 2024, advancing treatments in areas such as cancer, rare diseases, neurology, infections, and conditions like schizophrenia, pain, and Alzheimer's. Consequently, the increasing number of novel drug approvals drives the growth of the pharmaceutical stability and storage services market.

Major companies operating in the pharmaceutical stability and storage services market are concentrating on developing technologically advanced solutions, such as cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, to safeguard temperature-sensitive biological and pharmaceutical materials, including cell therapies, vaccines, and biologics. For example, in December 2024, Astoriom, a UK-based stability and biospecimen storage company, unveiled a cryogenic storage suite at its Tramore facility in County Waterford, Ireland, representing a significant enhancement of its capabilities for biological sample storage. This advanced suite is designed to address the growing need for safe, long-term preservation of biological materials, ensuring their viability over extended periods. The storage system offers precise temperature control down to -196°C, extensive storage capacity, ISO 9001 certification for regulatory compliance, and sophisticated security measures, including access controls and monitoring systems.

In January 2024, Alcami Corporation, a US-based contract development and manufacturing organization (CDMO), acquired Pacific Pharmaceutical Services, Inc. for an undisclosed amount. Through this acquisition, Alcami seeks to broaden its pharmaceutical storage and service capabilities, improve bi-coastal service coverage, and enhance its capacity to manage pre-clinical and clinical materials with greater security and multi-location resilience. Pacific Pharmaceutical Services, Inc. is a US-based company providing pharmaceutical clinical distribution services, offering stability and storage solutions, including a range of cGMP-compliant storage conditions from controlled room temperature to cryogenic temperatures.

Major companies operating in the pharmaceutical stability and storage services market are SGS S.A., Eurofins Scientific SE, Intertek Group plc, Catalent Inc., Almac Group, Alcami Corporation, Reading Scientific Services Ltd., Charles River Laboratories, Element Materials Technology Inc., Precision Stability Storage, Roylance Stability Storage Limited, BioLife Solutions Inc., Alloga UK Ltd., Auriga Research Private Limited, Q Laboratories Inc., ALS Limited, Lucideon Limited, Cencora Inc., PCI Pharma Services, DHL Life Sciences & Healthcare

North America was the largest region in the pharmaceutical stability and storage services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical stability and storage services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical stability and storage services market consists of revenues earned by entities by providing services such as photostability testing, cold chain management, disaster recovery and backup storage. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical stability and storage services market also includes sales of stability chambers, cryogenic storage systems, cold storage units and automated sample management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Stability And Storage Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical stability and storage services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical stability and storage services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical stability and storage services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Service: Stability; Storage
  • 2) By Product Type: Tablets; Capsules; Injectable Solutions; Oral Suspensions; Combination Products; Other Product Types
  • 3) By Molecule: Small Molecule; Large Molecule
  • 4) By Mode: In-House; Outsourcing
  • 5) By End User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Other End Users
  • Subsegments:
  • 1) By Stability Services: Long-Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing; Forced Degradation Studies
  • 2) By Storage Services: Ambient Storage; Refrigerated Storage (2°C to 8°C); Frozen Storage (-20°C to -80°C); Cryogenic Storage (-150°C to -196°C); Controlled Drug Substance And Product Storage
  • Companies Mentioned: SGS S.A.; Eurofins Scientific SE; Intertek Group plc; Catalent Inc.; Almac Group; Alcami Corporation; Reading Scientific Services Ltd.; Charles River Laboratories; Element Materials Technology Inc.; Precision Stability Storage; Roylance Stability Storage Limited; BioLife Solutions Inc.; Alloga UK Ltd.; Auriga Research Private Limited; Q Laboratories Inc.; ALS Limited; Lucideon Limited; Cencora Inc.; PCI Pharma Services; DHL Life Sciences & Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Stability And Storage Services Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharmaceutical Stability And Storage Services Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Stability And Storage Services Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharmaceutical Stability And Storage Services Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Sustainability, Climate Tech & Circular Economy
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Regulatory-Compliant Storage
    • 4.2.2 Increasing Outsourcing Of Stability Testing Services
    • 4.2.3 Growing Need For Cold Chain And Cryogenic Storage
    • 4.2.4 Expansion Of Stability Services For Biologics
    • 4.2.5 Higher Focus On Long-Term Drug Quality Assurance

5. Pharmaceutical Stability And Storage Services Market Analysis Of End Use Industries

  • 5.1 Biopharmaceutical Companies
  • 5.2 Contract Manufacturing Organizations
  • 5.3 Contract Research Organizations
  • 5.4 Clinical Trial Sponsors
  • 5.5 Vaccine Manufacturers

6. Pharmaceutical Stability And Storage Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Stability And Storage Services Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharmaceutical Stability And Storage Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharmaceutical Stability And Storage Services Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharmaceutical Stability And Storage Services Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharmaceutical Stability And Storage Services Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Stability And Storage Services Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Stability And Storage Services Market Segmentation

  • 9.1. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stability, Storage
  • 9.2. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types
  • 9.3. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Small Molecule, Large Molecule
  • 9.4. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In-House, Outsourcing
  • 9.5. Global Pharmaceutical Stability And Storage Services Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
  • 9.6. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Stability Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies
  • 9.7. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Storage Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage

10. Pharmaceutical Stability And Storage Services Market Regional And Country Analysis

  • 10.1. Global Pharmaceutical Stability And Storage Services Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharmaceutical Stability And Storage Services Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Stability And Storage Services Market

  • 11.1. Asia-Pacific Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Stability And Storage Services Market

  • 12.1. China Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Stability And Storage Services Market

  • 13.1. India Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Stability And Storage Services Market

  • 14.1. Japan Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Stability And Storage Services Market

  • 15.1. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Stability And Storage Services Market

  • 16.1. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Stability And Storage Services Market

  • 17.1. South Korea Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Stability And Storage Services Market

  • 18.1. Taiwan Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Stability And Storage Services Market

  • 19.1. South East Asia Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Stability And Storage Services Market

  • 20.1. Western Europe Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Stability And Storage Services Market

  • 21.1. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Stability And Storage Services Market

  • 22.1. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Stability And Storage Services Market

  • 23.1. France Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Stability And Storage Services Market

  • 24.1. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Stability And Storage Services Market

  • 25.1. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Stability And Storage Services Market

  • 26.1. Eastern Europe Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Stability And Storage Services Market

  • 27.1. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Stability And Storage Services Market

  • 28.1. North America Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Stability And Storage Services Market

  • 29.1. USA Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Stability And Storage Services Market

  • 30.1. Canada Pharmaceutical Stability And Storage Services Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Stability And Storage Services Market

  • 31.1. South America Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Stability And Storage Services Market

  • 32.1. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Stability And Storage Services Market

  • 33.1. Middle East Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Stability And Storage Services Market

  • 34.1. Africa Pharmaceutical Stability And Storage Services Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Segmentation By Product Type, Segmentation By Molecule, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Stability And Storage Services Market Regulatory and Investment Landscape

36. Pharmaceutical Stability And Storage Services Market Competitive Landscape And Company Profiles

  • 36.1. Pharmaceutical Stability And Storage Services Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharmaceutical Stability And Storage Services Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharmaceutical Stability And Storage Services Market Company Profiles
    • 36.3.1. SGS S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Intertek Group plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Stability And Storage Services Market Other Major And Innovative Companies

  • Alcami Corporation, Reading Scientific Services Ltd., Charles River Laboratories, Element Materials Technology Inc., Precision Stability Storage, Roylance Stability Storage Limited, BioLife Solutions Inc., Alloga UK Ltd., Auriga Research Private Limited, Q Laboratories Inc., ALS Limited, Lucideon Limited, Cencora Inc., PCI Pharma Services, DHL Life Sciences & Healthcare

38. Global Pharmaceutical Stability And Storage Services Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Stability And Storage Services Market

40. Pharmaceutical Stability And Storage Services Market High Potential Countries, Segments and Strategies

  • 40.1 Pharmaceutical Stability And Storage Services Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pharmaceutical Stability And Storage Services Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pharmaceutical Stability And Storage Services Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer